SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the H.C. Wainwright 24th Annual Global Investment Conference. Tricida will provide a company overview, business update and progress on the company’s key initiatives. The presentation will be accessible on the Tricida website at IR.Tricida.com on Monday, September 12, 2022 at … [Read more…]
CHAPEL HILL, N.C. & MALMO, Sweden–(BUSINESS WIRE)–Trialbee CEO Matt Walz has been named to the 2022 PharmaVoice 100 — an annual list that recognizes the most inspiring people in the life-sciences industry – for his work to increase access, diversity, and efficiency in clinical research. “With the number of clinical trials over the next five … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific External Urine Management Products Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Offline and Online), By Product, By End- use (Hospitals, Clinics, Home Care Settings), By Country and Growth Forecast, 2022 – 2028” report has been added to ResearchAndMarkets.com’s offering. The Asia Pacific External Urine Management Products Market … [Read more…]
BELLEVUE, Wash.–(BUSINESS WIRE)–#CurvaFixImplant—CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the completion of the 100th surgical procedure using the CurvaFix® IM Implant to repair a pelvic fragility fracture for a geriatric patient at University Hospital at the University of Missouri in Columbia, Mo. The surgery was performed by … [Read more…]
BURLINGAME, Calif.–(BUSINESS WIRE)–#DepressionTreatment—Magnus Medical, Inc., a medical device company and developer of brain stimulation technology for treatment of neuropsychiatric disorders, today announced it received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for the SAINTTM Neuromodulation System for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory … [Read more…]
ROCKVILLE, Md.–(BUSINESS WIRE)–#biotech–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of LAMP (Lysosome Associated Membrane Protein)-mediated nucleic acid-based immunotherapy, today announced the appointment of Frances Harrison as Senior Vice President, Regulatory Affairs. Ms. Harrison brings to the company more than 30 years of experience in global regulatory strategies and submissions, interactions, … [Read more…]
Study shows VivAer was effective in reducing symptoms of nasal airway obstruction for patients with both dynamic and static nasal valve collapse SUNNYVALE, Calif.–(BUSINESS WIRE)–#ENT—Aerin Medical Inc., a company that provides Ear, Nose and Throat (ENT) physicians with non-invasive solutions to treat chronic nasal conditions, today announced that JAMA Otolaryngology – Head & Neck Surgery … [Read more…]
FREMONT, Calif.–(BUSINESS WIRE)–Cyber-physical identity access management and security leader AlertEnterprise revealed the addition of its new Asset Governance module to their Guardian security convergence platform. AlertEnterprise Asset Governance connects individual digital identities to physical assets such as keys, computers and company vehicles helping organizations keep tabs on and protect physical assets from the moment they’re … [Read more…]
2022 User Satisfaction Survey names Veradigm Payerpath the top solution for End-To-End RCM Software Technology, supporting Physicians Practices & Ambulatory Facilities/Groups CHICAGO–(BUSINESS WIRE)–$MDRX #healthIT—Veradigm®, a leading provider of healthcare data and technology solutions and a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), today announced that Black Book, a healthcare-centric market research and public opinion … [Read more…]
Late-breaking data from DESTINY-Lung02 phase 2 trial of ENHERTU in patients with previously treated HER2 mutant metastatic non-small cell lung cancer to be featured Proffered paper presentation to highlight updated results from phase 1/2 trial of DS-7300 in several types of cancer including lung, esophageal and prostate MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo (TSE: … [Read more…]
